The company said net sales for the quarter ended December 31, 2024 were $21.9 billion, an increase of 2% versus the prior year, and organic sales, which exclude the impacts of foreign exchange and acquisitions and divestitures, increased 3%.

1. 01

   The company said net sales for the quarter ended December 31, 2024 were $21.9 billion, an increase of 2% versus the prior year, and organic sales, which exclude the impacts of foreign exchange and acquisitions and divestitures, increased 3%.

2. 02

   The company said diluted net earnings per share for the quarter were $1.88, an increase of 34% versus the prior year, and core EPS were $1.88, an increase of 2%. It cited the Gillette intangible asset non-cash impairment charge in the base period as a factor in the diluted EPS increase.

3. 03

   The company said operating cash flow for the quarter was $4.8 billion and net earnings were $4.7 billion, with adjusted free cash flow productivity of 84%. It also said the company returned over $4.9 billion of cash to shareowners via $2.4 billion of dividend payments and $2.5 billion of share repurchases.

4. 04

   The company maintained its guidance for fiscal 2025 all-in sales growth in the range of 2 to 4%, organic sales growth in the range of 3 to 5%, and core EPS growth in the range of 5 to 7%, which equates to a range of $6.91 to $7.05 per share.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.